ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Retsevmo 40 mg, gélules - 56
67862004 Eli Lilly (Suisse) SA
Retsevmo 40 mg, gélules08.02.2021
  08.02.2021
Selpercatinib (L01EX22) 
WHO-DDD19.12.2029
07.16.10.56
07.16.10. 
A  
Yes 
IPCI
1958.87Yes
    
10 %2146.80
  
7680678620040Synthetika
  
Composition
Capsule: selpercatinibum 40 mg, cellulosum microcristallinum, silica colloidalis anhydrica, matériel de la capsule: gelatina, E 171, E 172 (nigrum), encre: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDoseadditional_information
Selpercatinibum40 mgCapsule
BAG: Active AgentDose
Selpercatinibum40 mg
 
Inactive agents additional_information
(Nigrum)  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Gelatina matériel de la capsule
Kalii Hydroxidum  
Lacca encre
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
 
Source
Data was imported : 07.01.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home